Keywords: Aβ; amyloid β peptide; AD; Alzheimerʹs Disease; ALS; amyotrophic lateral sclerosis; Amb; Amphotericin B; BBB; blood-brain barrier; CJD; Creutzfeld Jakob disease; CSF; cerebral spinal fluid; DCS; D-Cycloserine; DOX; Doxorubicin; GA; Geldanamycin; GAPDH;